Trial
NCT02334527
Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
Pfizer
Condition
Metastatic Urothelial Carcinoma (UC)
Intervention
Palbociclib
Why stopped
Data from first 12 subjects-primary endpoint not met. Data analysis underway.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-16